LAVA Therapeutics Statistics
Total Valuation
LVTX has a market cap or net worth of $32.62 million. The enterprise value is -$38.68 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
Earnings Date | May 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
LVTX has 26.31 million shares outstanding. The number of shares has increased by 0.38% in one year.
Current Share Class | 26.31M |
Shares Outstanding | 26.31M |
Shares Change (YoY) | +0.38% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 0.42% |
Owned by Institutions (%) | 10.02% |
Float | 10.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.78 |
Forward PS | n/a |
PB Ratio | 1.18 |
P/TBV Ratio | 1.18 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.40, with a Debt / Equity ratio of 0.19.
Current Ratio | 4.40 |
Quick Ratio | 4.25 |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -50.08 |
Financial Efficiency
Return on equity (ROE) is -63.49% and return on invested capital (ROIC) is -35.62%.
Return on Equity (ROE) | -63.49% |
Return on Assets (ROA) | -17.67% |
Return on Invested Capital (ROIC) | -35.62% |
Return on Capital Employed (ROCE) | -41.06% |
Revenue Per Employee | $352,412 |
Profits Per Employee | -$738,647 |
Employee Count | 34 |
Asset Turnover | 0.13 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, LVTX has paid $630,000 in taxes.
Income Tax | 630,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.08% in the last 52 weeks. The beta is 0.45, so LVTX's price volatility has been lower than the market average.
Beta (5Y) | 0.45 |
52-Week Price Change | -59.08% |
50-Day Moving Average | 1.27 |
200-Day Moving Average | 1.46 |
Relative Strength Index (RSI) | 48.25 |
Average Volume (20 Days) | 46,708 |
Short Selling Information
The latest short interest is 114,247, so 0.43% of the outstanding shares have been sold short.
Short Interest | 114,247 |
Short Previous Month | 137,072 |
Short % of Shares Out | 0.43% |
Short % of Float | 1.12% |
Short Ratio (days to cover) | 2.24 |
Income Statement
In the last 12 months, LVTX had revenue of $11.98 million and -$25.11 million in losses. Loss per share was -$0.94.
Revenue | 11.98M |
Gross Profit | -12.57M |
Operating Income | -25.79M |
Pretax Income | -28.31M |
Net Income | -25.11M |
EBITDA | -25.33M |
EBIT | -25.79M |
Loss Per Share | -$0.94 |
Full Income Statement Balance Sheet
The company has $76.58 million in cash and $5.28 million in debt, giving a net cash position of $71.30 million or $2.71 per share.
Cash & Cash Equivalents | 76.58M |
Total Debt | 5.28M |
Net Cash | 71.30M |
Net Cash Per Share | $2.71 |
Equity (Book Value) | 27.75M |
Book Value Per Share | 1.05 |
Working Capital | 61.29M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$19.54 million and capital expenditures -$23,000, giving a free cash flow of -$19.57 million.
Operating Cash Flow | -19.54M |
Capital Expenditures | -23,000 |
Free Cash Flow | -19.57M |
FCF Per Share | -$0.74 |
Full Cash Flow Statement Margins
Gross margin is -104.89%, with operating and profit margins of -215.26% and -209.60%.
Gross Margin | -104.89% |
Operating Margin | -215.26% |
Pretax Margin | -204.34% |
Profit Margin | -209.60% |
EBITDA Margin | -211.37% |
EBIT Margin | -215.26% |
FCF Margin | n/a |
Dividends & Yields
LVTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.38% |
Shareholder Yield | -0.38% |
Earnings Yield | -76.99% |
FCF Yield | -59.99% |
Analyst Forecast
The average price target for LVTX is $3.17, which is 155.65% higher than the current price. The consensus rating is "Hold".
Price Target | $3.17 |
Price Target Difference | 155.65% |
Analyst Consensus | Hold |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -15.33% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LVTX has an Altman Z-Score of -2.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.41 |
Piotroski F-Score | 3 |